(Q45214571)

10 December 2017

title

A multicenter pilot study of early (4-day) steroid cessation in renal transplant recipients under simulect, tacrolimus and sirolimus (English)

1 reference

10 December 2017

1

E Steve Woodle

1 reference

10 December 2017

Flavio Vincenti

2

1 reference

10 December 2017

Marc I Lorber

3

1 reference

10 December 2017

H Albin Gritsch

4

1 reference

10 December 2017

Donald Hricik

5

1 reference

10 December 2017

Kenneth Washburn

6

1 reference

10 December 2017

Arthur J Matas

7

1 reference

10 December 2017

Michael Gallichio

8

1 reference

10 December 2017

John Neylan

9

1 reference

10 December 2017

language of work or name

English

0 references

publication date

1 January 2005

1 reference

American Journal of Transplantation

10 December 2017

published in

1 reference

10 December 2017

volume

5

1 reference

10 December 2017

issue

1

1 reference

10 December 2017

page(s)

157-166

1 reference

Early steroid withdrawal in renal transplantation with tacrolimus dual therapy: a pilot study

10 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00655.X

The use of an anti-CD25 monoclonal antibody and mycophenolate mofetil enables the use of a low-dose tacrolimus and early withdrawal of steroids in renal transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00655.X

Sirolimus permits steroid withdrawal from a cyclosporine regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00655.X

Rapamycin in combination with cyclosporine or tacrolimus in liver, pancreas, and kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00655.X

Dyslipidemia in renal transplant recipients treated with a sirolimus and cyclosporine-based immunosuppressive regimen: incidence, risk factors, progression, and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00655.X

Immunosuppressive effects and safety of a sirolimus/cyclosporine combination regimen for renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00655.X

Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00655.X

Therapeutic drug monitoring of sirolimus: correlations with efficacy and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00655.X

Sirolimus (rapamycin)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine. Sirolimus European Renal Transplant Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00655.X

Sirolimus does not exhibit nephrotoxicity compared to cyclosporine in renal transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00655.X

Comparison of sirolimus vs. mycophenolate mofetil on surgical complications and wound healing in adult kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00655.X

Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00655.X

10.1111/J.1600-6143.2004.00655.X

21 January 2018

Identifiers

DOI

1 reference

10 December 2017

1 reference